Tobira Therapeutics
(TBRA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
| Sales | 1,058 | 107 | 0 | 0 | 0 |
| Gross Profit | 1,058 | 107 | N/A | N/A | N/A |
| Operating Expenses | 14,008 | 12,020 | 9,067 | 26,233 | 9,735 |
| Operating Income | -12,950 | -11,913 | -9,067 | -26,233 | -9,735 |
| Interest Expense | 310 | 308 | 321 | 335 | 1,190 |
| Other Income | 0 | 0 | 0 | 0 | -97 |
| Pre-tax Income | -13,260 | -12,221 | -9,388 | -26,568 | -11,022 |
| Income Tax | 83 | N/A | -1 | -4,357 | -35 |
| Net Income Continuous | -13,343 | -12,221 | -9,387 | -22,211 | -10,987 |
| Net Income | $-13,343 | $-12,221 | $-9,387 | $-22,211 | $-10,987 |
| EPS Basic Total Ops | -0.71 | -0.65 | 15.56 | -1.22 | -0.99 |
| EPS Basic Continuous Ops | -0.71 | -0.65 | 15.54 | -1.22 | -0.99 |
| EPS Diluted Total Ops | -0.71 | -0.65 | 15.56 | -1.22 | -0.99 |
| EPS Diluted Continuous Ops | -0.71 | -0.65 | 15.54 | -1.22 | -0.99 |
| EPS Diluted Before Non-Recurring Items | -0.71 | -0.65 | -0.50 | -0.60 | -0.99 |
| EBITDA(a) | $-12,853 | $-11,817 | $-8,969 | $-8,812 | $-9,126 |